Blueprint Medicines Corp Insider Trading for June 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Blueprint Medicines Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Blueprint Medicines Corp for June 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30 2017 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Option Exercise | M | 8.80 | 10,000 | 88,000 | 179,544 | |
| Jun 30 2017 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Sell | S | 49.07 | 1,100 | 53,977 | 0 | 1.1 K to 0 (-100.00 %) |
| Jun 30 2017 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Sell | S | 50.19 | 4,314 | 216,520 | 1,100 | 5.4 K to 1.1 K (-79.68 %) |
| Jun 30 2017 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Sell | S | 51.08 | 4,586 | 234,253 | 5,414 | 10 K to 5.4 K (-45.86 %) |
| Jun 30 2017 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Buy | M | 8.80 | 10,000 | 88,000 | 10,000 | 0 to 10 K |
| Jun 30 2017 | BPMC | Blueprint Medicine ... | LYNCH DANIEL | Director | Sell | S | 49.09 | 3,125 | 153,406 | 219,342 | 222.5 K to 219.3 K (-1.40 %) |
| Jun 30 2017 | BPMC | Blueprint Medicine ... | LYNCH DANIEL | Director | Sell | S | 50.12 | 21,474 | 1,076,277 | 222,467 | 243.9 K to 222.5 K (-8.80 %) |
| Jun 30 2017 | BPMC | Blueprint Medicine ... | LYNCH DANIEL | Director | Sell | S | 51.17 | 7,901 | 404,294 | 243,941 | 251.8 K to 243.9 K (-3.14 %) |
| Jun 30 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 49.10 | 2,229 | 109,444 | 35,486 | 37.7 K to 35.5 K (-5.91 %) |
| Jun 30 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 50.22 | 10,205 | 512,495 | 37,715 | 47.9 K to 37.7 K (-21.30 %) |
| Jun 30 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 51.21 | 7,566 | 387,455 | 47,920 | 55.5 K to 47.9 K (-13.64 %) |
| Jun 30 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Option Exercise | M | 16.28 | 6,357 | 103,492 | 120,929 | |
| Jun 30 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Sell | S | 50.00 | 6,357 | 317,850 | 0 | 6.4 K to 0 (-100.00 %) |
| Jun 30 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Buy | M | 16.28 | 6,357 | 103,492 | 6,357 | 0 to 6.4 K |
| Jun 23 2017 | BPMC | Blueprint Medicine ... | Borisy Alexis | Director | Option Exercise | A | 46.02 | 10,909 | 502,032 | 21,818 | |
| Jun 23 2017 | BPMC | Blueprint Medicine ... | Demetri George | Director | Option Exercise | A | 46.02 | 10,909 | 502,032 | 57,271 | |
| Jun 23 2017 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Option Exercise | A | 46.02 | 10,909 | 502,032 | 21,818 | |
| Jun 23 2017 | BPMC | Blueprint Medicine ... | LYNCH DANIEL | Director | Option Exercise | A | 46.02 | 10,909 | 502,032 | 21,818 | |
| Jun 23 2017 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | A | 46.02 | 10,909 | 502,032 | 43,636 | |
| Jun 23 2017 | BPMC | Blueprint Medicine ... | COATS LONNEL | Director | Option Exercise | A | 46.02 | 10,909 | 502,032 | 43,636 | |
| Jun 23 2017 | BPMC | Blueprint Medicine ... | Seely Lynn | Director | Option Exercise | A | 46.02 | 10,909 | 502,032 | 43,636 | |
| Jun 23 2017 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | A | 46.02 | 10,909 | 502,032 | 43,636 |